aid: civitas-therapeutics
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/civitas-therapeutics.png
name: Civitas Therapeutics
description: Civitas Therapeutics was a privately held biopharmaceutical company founded in 2009 (Chelsea/Cambridge,
  Massachusetts) that developed inhaled therapeutics using the proprietary ARCUS dry-powder pulmonary delivery
  platform. Its lead program, CVT-301, was an inhaled levodopa therapy for the rapid relief of OFF episodes
  in Parkinson's disease patients. The company was acquired by Acorda Therapeutics in 2014 for approximately
  $525 million and no longer operates as an independent entity. It is a life-sciences / drug-development company
  with no public developer platform, API, SDK, or technical integration surface. Surfaced as a portfolio company
  of canaan-partners and retained in the API Evangelist network for provenance.
url: https://raw.githubusercontent.com/api-evangelist/civitas-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- canaan-partners
x-tier: stub
x-tier-reason: portfolio-lead
x-status: acquired
x-acquired-by: Acorda Therapeutics
x-acquired-year: 2014
x-api-surface: none
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-20'
tags:
- Company
- Biopharmaceutical
- Pharmaceuticals
- Life Sciences
- Drug Development
- Inhalation Therapy
- Parkinsons Disease
- Acquired
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-20'
  status: nochange
  artifacts_added: 0
  pass: local-v1